Clinical Trial Update: Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503) [Phase 2]

View source ↗

Summary

This Phase 2 trial (BMT CTN 1503) compares bone marrow transplantation versus standard of care in patients with severe sickle cell disease, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Sickle Cell Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-09-24